About Osler Diagnostics
Osler Diagnostics is a company based in Oxford (United Kingdom) founded in 2017 by Connor Campbell. Osler Diagnostics has raised $85 million across 1 funding round from investors including M&G, Oxford Science Enterprises and Braavos. Osler Diagnostics offers products and services including Osler Origin and Osler HemaTap. Osler Diagnostics operates in a competitive market with competitors including Dexcom, Livongo, One Drop, Bigfoot Biomedical and mySugr, among others.
- Headquarter Oxford, United Kingdom
- Founders Connor Campbell
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Osler Diagnostics Limited
- Date of Incorporation 11 Feb, 2016
- Jurisdiction OXFORD, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$85 M (USD)
in 1 rounds
-
Latest Funding Round
$85 M (USD), Series C
Nov 07, 2022
-
Investors
M&G
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Osler Diagnostics
Osler Diagnostics offers a comprehensive portfolio of products and services, including Osler Origin and Osler HemaTap.
Portable instrument for comprehensive, multiplexed health tests.
Technology for microfluidic blood sample handling in diagnostics.
People of Osler Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Osler Diagnostics
Osler Diagnostics has successfully raised a total of $85M through 1 strategic funding round. The most recent funding activity was a Series C round of $85 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Osler Diagnostics
Osler Diagnostics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include M&G, Oxford Science Enterprises and Braavos.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified asset management firm and private fund focused on debt and equity investments in climate startups, real estate, and multiple sectors
|
Locked | Locked | Locked | |
|
Investment management services for science ventures are provided in Oxford.
|
Locked | Locked | Locked | |
|
Braavos is associated with multiple companies.
|
Locked | Locked | Locked |
Investor details for Osler Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Osler Diagnostics
Investment portfolio details for Osler Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Osler Diagnostics
Detailed financials for Osler Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Osler Diagnostics Comparisons
Peer comparison for Osler Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Osler Diagnostics
Osler Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, Bigfoot Biomedical and mySugr, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| Locked | Locked | Locked |
Provider of smart devices for diabetes management for patients and doctors
|
|
| Locked | Locked | Locked |
Provider of workforce healthcare solutions
|
|
| Locked | Locked | Locked |
Developer of a closed-loop automated insulin delivery system
|
|
| Locked | Locked | Locked |
Gamified apps for diabetes management and therapy are provided.
|
|
| Locked | Locked | Locked |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
Detailed competitors of Osler Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Osler Diagnostics
Complete news archive for Osler Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Osler Diagnostics
Osler Diagnostics was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Osler Diagnostics is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Connor Campbell is the current CEO of Osler Diagnostics. They have also founded this company.
Osler Diagnostics is a funded company, having raised a total of $85M across 1 funding round to date.
Osler Diagnostics was founded in 2017 in Oxford, United Kingdom, within the medical diagnostics sector. Portable electrochemical blood glucose sensor devices are developed and supplied by the company to facilitate point-of-care testing. Operations focus on innovative sensor technology for glucose monitoring, with leadership provided by Co-Founder and CEO Connor Campbell. The companys domain is oslerdiagnostics.com, supporting its activities in the health technology field.
Osler Diagnostics's top competitors include Dexcom, Senseonics and Bigfoot Biomedical.
Osler Diagnostics offers Osler Origin and Osler HemaTap.
Osler Diagnostics has 4 investors. Key investors include M&G, Oxford Science Enterprises, Braavos, and Lansdowne Partners.